Regina Miracle FY26 Net Profit Up by 53.9% to HK$280 Million

Highlights- Resilient Overall Performance: Total revenue reached HK$7,717.7 million for Fiscal 2026, maintaining business stability amid macroeconomic volatility and a polarized consumer market- Continued Robust Performance of VS China, Effective Cost Reduction and Efficiency Enhancement Initiatives: The Group’s net profit grew 53.9% to HK$283.0 million, and basic earnings per share…

CanSinoBIO’s MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America

HONG KONG, Jun 29, 2026 - (ACN Newswire via SeaPRwire.com) - On June 25, CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the "MCV4", trade name: Menhycia(R)) has recently received the drug registration certificate granted by the Administración Nacional de Medicamentos, Alimentos…

Ching Lee Holdings (3728.HK) Reports Resilient Performance with Revenue Growth Amid Margin Pressure

HONG KONG, Jun 29, 2026 - (ACN Newswire via SeaPRwire.com) - Ching Lee Holdings Limited (the “Group”, stock code: 3728.HK) announced its annual results for the twelve months ended 31 March 2026. Revenue increased by 14% year-on-year to approximately HK$1.47 billion.All operating segments recorded growth during the year. Revenue contributions included…